Lycia Therapeutics Shares Rise 32% in Trading Debut After $317.5 Million IPO
Lycia Therapeutics shares recently traded at $23.70, up 32%, after the clinical-stage biotech raised $317.5 million in an upsized IPO priced at the high end of expectations.
By Colin KellaherShares of Lycia Therapeutics surged in their trading debut Friday after the clinical-stage biotechnology company's upsized initial public offering was priced at the high end of expectations, raising $317.5 million.Lycia shares were recently changing hands at $23.70, up 32%, after o…